https://www.bioworld.com/rss en-us The New England Journal of Medicine.]]> http://www.bioworld.com/articles/731516 Mon, 01 Jun 2026 12:00:00 -0400 https://www.bioworld.com/articles/731516-asco-2026-a-revolution-in-pancreatic-cancer Pancreas 3D hologram http://www.bioworld.com/articles/731515 Mon, 01 Jun 2026 12:00:00 -0400 https://www.bioworld.com/articles/731515-asco-2026-grail-shifts-focus-to-secondary-endpoints-in-uk-study Grail Galleri multicancer early detection test Credit: Grail Inc. http://www.bioworld.com/articles/731513 Mon, 01 Jun 2026 12:00:00 -0400 https://www.bioworld.com/articles/731513-asco-2026-pd-l1-x-vegf-bispecifics-fight-it-out Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow http://www.bioworld.com/articles/731566 Mon, 01 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731566-aleksia-therapeutics-patents-new-cdk2-inhibitors http://www.bioworld.com/articles/731561 Mon, 01 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731561-xtalpi-reports-milestones-under-dovetree-collaboration Illustration of medical professionals, research http://www.bioworld.com/articles/731560 Mon, 01 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731560-targeting-uch-l1-could-enhance-sorafenib-efficacy-in-hcc Photomicrograph of hepatocellular carcinoma Photomicrograph of hepatocellular carcinoma. http://www.bioworld.com/articles/731559 Mon, 01 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731559-laverock-therapeutics-awarded-innovation-grants Dollar sign in light bulb on yellow background http://www.bioworld.com/articles/731556 Mon, 01 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731556-alaw-nominates-cdk4-inhibitor-al-433-as-development-candidate Pink and orange test tubes http://www.bioworld.com/articles/731554 Mon, 01 Jun 2026 09:00:00 -0400 https://www.bioworld.com/articles/731554-smyd2-is-a-dual-regulator-of-proliferation-and-immunosuppression-in-hcc http://www.bioworld.com/articles/731458 Fri, 29 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731458-adcs-multispecific-antibodies-anchor-10b-pfizer-innovent-deal Antibodies attacking cancer cell http://www.bioworld.com/articles/731454 Fri, 29 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731454-bms-mezigdomide-doubles-pfs-in-multiple-myeloma Healthy (left) vs. cancerous bone marrow http://www.bioworld.com/articles/731453 Fri, 29 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731453-replimune-tries-again-with-melanoma-drug-post-fda-shakeup Skin exam http://www.bioworld.com/articles/731507 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731507-norroy-bioscience-discloses-fap-targeted-pet-imaging-agents http://www.bioworld.com/articles/731506 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731506-university-of-california-patents-inhibitors-of-parp-1-dna-repair-and-atr http://www.bioworld.com/articles/731505 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731505-synnovation-therapeutics-synthesizes-new-nrf2-degraders http://www.bioworld.com/articles/731504 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731504-shanghai-kezhou-drug-development-discovers-new-kras-mutant-inhibitors http://www.bioworld.com/articles/731503 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731503-zhize-tongkang-guangzhou-biotechnology-prepares-new-anti-cldn6-adcs http://www.bioworld.com/articles/731493 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731493-alg-093940-shows-promise-for-liver-cancer-and-hepatitis-b Liver illustration http://www.bioworld.com/articles/731492 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731492-innovent-pfizer-partner-on-12-early-stage-cancer-programs Black and white arrows merging into one http://www.bioworld.com/articles/731491 Fri, 29 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731491-pancreatic-lesions-show-cancer-traits-but-lack-stromal-support Immunofluorescence image of human donor pancreas with a precursor lesion lined by epithelial cells surrounded by fibroblasts. Immunofluorescence image of human donor pancreas with a precursor lesion lined by epithelial cells surrounded by fibroblasts. Credit: Pasca Lab http://www.bioworld.com/articles/731444 Thu, 28 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731444-trop2-adcs-progress-into-first-line-for-lung-breast-cancers Floating antibody drug conjugates http://www.bioworld.com/articles/731440 Thu, 28 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731440-elzonris-this-fda-clears-abbvies-decnupaz-in-bpdcn Blood cells and destruction of cancer cell http://www.bioworld.com/articles/731487 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731487-anti-egfr-antibody-drug-conjugates-reported-in-hutchmed-patent http://www.bioworld.com/articles/731486 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731486-amplia-therapeutics-identifies-new-fak-inhibitors http://www.bioworld.com/articles/731485 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731485-scinnohub-pharmaceutical-patents-new-menin-mll-interaction-inhibitors http://www.bioworld.com/articles/731484 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731484-open-source-therapeutics-divulges-new-parp-1-inhibitors http://www.bioworld.com/articles/731477 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731477-protuoso-biosciences-building-multifunctional-protein-engineering-platform Drug R&D concept image. http://www.bioworld.com/articles/731476 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731476-reprogram-biosciences-secures-financing-for-solid-tumor-mrna-work Wireframe hands, coins http://www.bioworld.com/articles/731475 Thu, 28 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731475-oricells-oric-902-shows-robust-results-in-hcc Red CAR T cell on blue blackground http://www.bioworld.com/articles/731304 Wed, 27 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731304-alterome-therapeutics-patents-new-gtpase-kras-inhibitors